Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
GlobeNewswire
Today at 4:27pm UTC
Housing Florence Italy: Affordable and Comfortable Student Accommodation in Florence
Globe PR Wire
Today at 4:27pm UTC
Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million...
GlobeNewswire
Today at 4:24pm UTC
LiberNovo Goes Global: New Markets & A Vision for Healthy Workspaces
PR Newswire
Today at 4:00pm UTC
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
GlobeNewswire
Today at 4:00pm UTC
FLY Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of January 12, 2026 Deadline in Securities Fraud Class Action...
PR Newswire
Today at 3:41pm UTC
Ascent Solutions Appoints Previous Microsoft Sales Leader Jeff Mutschler as Senior Vice President of Alliances
PR Newswire
Today at 3:30pm UTC
SFM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sprouts Farmers Market, Inc. Investors with Substantial Losses Have...
PR Newswire
Today at 3:20pm UTC
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH...
GlobeNewswire
Today at 3:15pm UTC
OQ Hair's Burmese Curly Bundles Gain Momentum as Customers Praise Their Natural Look and Steady Curl Pattern
WebWire
Today at 3:10pm UTC
Lordsbook Launches Its New App & Is Leading The Way To Christian Community & Discipleship
PR Newswire
Today at 3:05pm UTC
When to Choose Veneers vs. Partial Dentures
Evertise Digital
Today at 3:00pm UTC
JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
GlobeNewswire
Today at 3:00pm UTC
PRGO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have...
GlobeNewswire
Today at 2:50pm UTC
Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual...
PR Newswire
Today at 2:45pm UTC
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with...
GlobeNewswire
Today at 2:30pm UTC
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple...
PR Newswire
Today at 2:30pm UTC
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th...
GlobeNewswire
Today at 2:30pm UTC
BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and...
GlobeNewswire
Today at 2:25pm UTC
Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
PR Newswire
Today at 2:20pm UTC